Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04996381
Other study ID # YonseiU
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2022
Est. completion date September 1, 2022

Study information

Verified date September 2022
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators will develop an artificial intelligence model to predict left ventricular ejection fraction using chest radiographic images and transthoracic echocardiography data.


Description:

Echocardiography should be considered at an early stage in patients who have first developed heart failure or who do not have information about heart function, but the examination may be delayed due to lack of time and manpower in the actual medical field. Primary Objective: Use chest radiographs to predict the left ventricular ejection fraction


Recruitment information / eligibility

Status Completed
Enrollment 505
Est. completion date September 1, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: - Adults who are 20 years and older - Patient who visited the emergency room or outpatient clinic due to dyspnea and chest pain Exclusion Criteria: - Patient refusal - Uncertain radiographs or transthoracic echocardiography - Uncertain tests results

Study Design


Related Conditions & MeSH terms

  • Chest X-ray for Clinical Evaluation

Intervention

Diagnostic Test:
Scanning Chest X-rays and performing AI algorithms on images
Chest X-Rays; AI CNNs; Results

Locations

Country Name City State
Korea, Republic of Yongin Severance Hospital Yongin Giheung-gu

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Left Ventricular Ejection Fraction < 40% Evaluate the performance of chest X-ray based artificial intelligence algorithms to identify individuals with reduced ejection fraction (<40%) Within two weeks of chest X-ray
See also
  Status Clinical Trial Phase
Completed NCT03935737 - Validation of a New Post Image Processing Engine (S-Vue™) for the Reduction of Ionizing Radiation Dose on X-ray Examination in Pediatric Patients